Abstract
gen consumption, an impairment of coronary reserve, and a reduction in myocardial contractility, and eventually to heart failure. LVH is now known to be an independent risk w x factor for cardiovascular events 1 .
Ž . The spontaneously hypertensive rat SHR , which develops hypertension and LVH spontaneously in its life time, has been utilized as an animal model of human Time for primary review 28 days.
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Downloaded from https://academic.oup.com/cardiovascres/article-abstract/38/2/365/299544 by guest on 10 December 2018 ( )primary hypertension. While the mechanism of development of hypertension and LVH in SHR is not fully understood, several factors have been suggested to play a role in the induction of LVH. These include mechanical stress, alteration in the sympathetic nervous system, and activaw x tion of the renin-angiotensin system 2-4 .
Several growth factors are reported to contribute to w x cardiac hypertrophy, including TGF-b, the FGFs 5 , IGF-1 w x 6 . Levels of message encoding heparin-binding epidermal Ž . growth factor-like growth factor HB-EGF , a member of w x the EGF family 7 , were recently shown to be markedly increased in isolated neonatal and adult myocytes by aadrenergic or continual pacing stimuli, and it was suggested that HB-EGF may be associated with an increase in w x total protein content in myocytes 8 . Unlike insulin and IGFs, however, EGF and other growth factors were found to be limited in their ability to induce hypertrophy in w x cultured adult rabbit heart cells 9 . Thus, it is unclear if HB-EGF and its signal transduction system participate in the process of myocyte hypertrophy, or to cardiac hypertrophy in vivo.
HB-EGF was originally reported to function as a mitogen for fibroblasts and vascular smooth muscle cells, and it has been shown to exert its activity through the EGF-rew x ceptor 10 . In inducing vascular smooth muscle cell proliferation, HB-EGF was observed to be more potent than EGF or TGF-a, but to have the same potency as PDGF w x 10 . This enhanced activity may be due to the cell-surface heparan sulfate proteoglycans, which have been found to w x facilitate HB-EGF binding to the EGF-receptor 10 . HB-EGF is expressed by fetal human vascular smooth muscle w x cells 11,12 , which synthesize and secrete the active mitogen.
Myocytes share a number of phenotypic characteristics with vascular smooth muscle cells, including similar functional responses to neurohumoral agonists and peptide w x autacoids, such as the endothelins 13 and angiotensin II w x 14 , and similar growth response to many peptide mitow x gens, including basic fibroblast growth factor 5 . Com-Ž . pared to aortic smooth muscle cells SMC from WKY, SMC from SHR were found to display an increased growth w x response to EGF 15 , suggesting that the HB-EGF signal transduction system may play a significant role in the development of LVH in SHR.
In addition to its ability to induce myocyte hypertrophy, EGF has been shown to trigger proliferation of mesenchymal cells in chicken hearts by a mechanism similar to that w x of insulin 16 . HB-EGF has also been observed to function as a juxtacrine growth factor, promoting the growth of w x one cell while still tethered to another 17 . These findings suggest that HB-EGF may be important for the proliferation of mesenchymal cells, and may promote the development of cardiac fibrosis in SHR by a paracrine or juxtacrine mechanism.
In order to test these hypothesis, we assayed the levels of expression of HB-EGF and EGF-receptor mRNA and protein in the left ventricle during the development of LVH in SHR. In addition, to investigate the mechanisms that regulate the expression of HB-EGF and its receptor in LVH of SHR, we tested the effects of an angiotensin-converting enzyme inhibitor and of a b -adrenoreceptor antag-1 onist, which modulate the development of LVH in SHR w x 4,18 , on the expression of HB-EGF and EGF-receptor mRNA in these rats.
Methods

Animals
Ž . Male Wistar Kyoto rat WKY rIzm and SHRrIzm were from inbred original strains established at Kyoto University and maintained at Shimane Medical University under strict genetic control. They were fed standard labora-Ž . tory chow Funabashi SP diet and given tap water ad libitum, from 4 weeks of age in our laboratory.
Protocols
Beginning at 4 weeks of age, systolic blood pressure was measured in each rat at weekly intervals by the tail Ž plethysmography method TK-370C: UNICOM, Chiba, . JAPAN . At 5, 9, 12 weeks of age, six animals in each group were killed by decapitation. Their hearts were rapidly removed, the atria and great vessels were trimmed away, and the remainder was rinsed in cold saline. Each heart was divided into the left ventricular free wall and the septal wall and right ventricle. Each portion was weighed and divided into two pieces. One portion, for RNA preparation, was rapidly frozen in liquid nitrogen and stored at y808C. The second portion, for immunohistochemistry, was divided into small pieces, embedded into O.C.T compound, frozen in liquid nitrogen, and stored at y808C.
In a second experiment, twenty-four 4-week-old rats in each strain were divided into four groups of six rats each. Ž . Group 1 the control group was given vehicle alone Ž . saline ; group 2 was given 10 mgrkgrday enalapril Ž . Sigma Chemical, St. Louis, MO ; group 3 was given 100 Ž . mgrkgrday atenolol Sigma ; and group 4 was given both enalapril and atenolol, at the same dose as above. Reagents were administered by gastric tube once a day, in the morning, for 5 weeks. Systolic blood pressure was measured weekly 5 h after the administration of reagents. At 9 Ž weeks of age, the rats were decapitated and the LV free . wall and septum and RV were immediately excised, and the tissue samples treated as described above. The prelimi-Ž . nary experiments with enalapril 5, 10, 20 mgrkgrday showed that 10 mgrkgrday of enalapril from 4 to 9 weeks of age decrease sBP in SHR to a level similar to that in Ž WKY, the preliminary experiments with atenolol 50, 100, . 200 mgrkgrday showed that the 100 mgrkgrday of atenolol had a similar effect on heart rate. All procedures were performed in accordance with the guidelines for animal research of the Asahikawa Medical College.
RNA extraction, Northern blotting and hybridization
Ž . q Ten-mg aliquots of poly A RNA, prepared as dew x scribed 19 , were electrophoresed through 1.0% agaroseformaldehyde gels, transferred to nitrocellulose filters Ž . BA-S85, Schleicher and Schuell , and prehybridized for 12 h at 428C with 50% formamide, 5 = SSC, 5 = Ž . Denhardt's solution, 25 mM sodium phosphate pH 6.5 , 0.1% SDS, 0.25 mgrml denatured salmon sperm DNA. The filters were hybridized at 428C overnight in the same solution, also containing a cDNA probe labeled with w 32 x P dCTP by random priming, and then washed under increasingly stringent conditions. Hybridization was visualized by autoradiography, and the radioactivity quantified with a bioimage analyzer and its accompanying software Ž . BAStation: Fuji Film, Tokyo, Japan . For each blot, hybridization signal of a b-actin probe was used to correct for differences in loading andror transfer.
cDNA probe
The probes utilized for Northern blot analysis included: HB-EGF, a 1.6-kb EcoRI-PstI rat cDNA fragment enw x compassing the entire coding region of HB-EGF 20 , the kind gift from Dr. Judith A. Abraham; EGF-receptor, a w x 4.2-kb XhoI-SacII human cDNA fragment 21 , the gift of the Riken Gene Bank; and b-actin, a 0.8-kb EcoRI canine cDNA fragment, the gift of Dr. Yoshihiro Ishikawa.
HB-EGF and EGF-receptor immunostaining
Rabbit antiserum to HB-EGF was produced using the synthetic peptide, H-1, consisting of HB-EGF precursor w x residues 185-208 22 . A mouse monoclonal antibody to human EGF receptor, produced using trypsinized A431 cells, was shown to cross-react with rat EGF receptor Ž . Transformation Research, Framingham, MA, USA . Mouse monoclonal antibodies to desmin and vimentin were purchased from Nichirei, Tokyo, Japan.
Immunohistochemistry was performed using the strepta-Ž vidin-biotin complex method Histofine, Nichirei, Tokyo, . Ž . Japan . Frozen sections about 5 mm thick were fixed in acetone at room temperature for 10 min, washed in phos-Ž . phate-buffered saline PBS , and incubated with 10% normal goat serum for 10 min at room temperature. Tissue sections were incubated overnight at 48C with a 1:120 Ž . dilution in PBS q1% bovine serum albumin of rabbit Ž . Ž anti-HB-EGF antiserum H-1 or a 1:100 dilution in the . same buffer of mouse anti-EGF-receptor monoclonal antibody, or with the appropriate dilution of mouse anti-desmin and anti-vimentin monoclonal antibodies. After washing in PBS, the sections were incubated for 10 min with a 1:200 dilution of biotinylated goat anti-rabbit IgG or goat anti-mouse IgG and then with the labeled streptavidin-Ž . biotin immunoperoxidase reagent Nichirei . Antigen-antibody complexes were visualized with 3,3
As a negative control, the primary antibody was re-Ž . placed by normal rabbit or mouse serum Nichirei .
Statistical analysis
Data are reported as mean " s.e.m., and were analyzed by the unpaired Student's t-test. A level of P -0.05 was considered statistically significant.
Result
Morphologic and hemodynamic changes in untreated SHR and WKY
In both strains of rats, we observed an increase in systolic blood pressure as a function of age; the increase, Ž . Ž . however, was greater in SHR P -0.05 Table 1 . In contrast, heart rate, which was significantly higher in SHR Ž . than in WKY at 5 and 9 weeks of age P -0.05 , was the Ž . same in both strains at 12 weeks of age Table 1 . The LVrBW ratio, an index of left ventricular hypertrophy, was also significantly higher in SHR than in age-matched Ž .Ž . WKY at all time points tested P -0.05 Table 1 . All of these data are in good agreement with previous reports w x Ž 23-25 . When we calculated double products i.e. systolic . blood pressure multiplied by heart rate , which is an index of mechanical load, we noted that this parameter was significantly higher in SHR than in WKY at all time points Ž . Ž P -0.01 vs. age-matched WKY at 5, 9, 12 weeks Fig. . 1A . In SHR, double products peaked at 9 weeks of age, and were significantly higher than at previous or subse-Ž quent time points P -0.01 vs. 5-week SHR, P -0.05 vs.
. Ž . 12-week SHR Fig. 1A . In contrast, the changes in Ž . double products over time were minor in WKY Fig. 1A . 
Expression of HB-EGF and EGF-receptor mRNA in untreated SHR and WKY
While a single 2.37-kb HB-EGF transcript was detected Ž . in the left ventricle LV of SHR and WKY at all time Ž . points tested Fig. 2A , the pattern of expression was Ž . clearly different in the two strains Fig. 2B . In WKY, the expression of HB-EGF mRNA gradually increased overtime, whereas, in SHR, there was a burst of expression at 9 Ž . weeks of age, with a decline thereafter only faintly detected in WKY at all ages examined, and Ž . did not change with age Fig. 3B .
Immunohistochemical staining for HB-EGF and EGF receptor
To elucidate the localization and the changes in protein level of HB-EGF and EGF-receptor, we immunohistochemically assayed rat heart tissue sections with antibodies to these two proteins. In addition, to discriminate myocytes from interstitial cells, we also assayed these samples with antibodies to desmin and vimentin. Antiserum to HB-EGF reacted primarily with myocyte membranes in 9-week-old Ž . SHR Fig. 4A ; this antiserum also reacted weakly with vascular smooth muscle in the coronary arteries of these Ž . rats data not shown . The pattern of immunostaining of HB-EGF in myocyte membranes was similar to that of desmin, a cytoskeletal protein specific for myocytes in Ž . mature hearts Fig. 4C . In contrast, EGF-receptor protein was localized mainly in interstitial cells and faintly in Ž . myocyte membranes Fig. 5A . The pattern of staining of EGF-receptor was similar to that of vimentin, a protein present mainly in myocardial fibroblasts in mature hearts Ž . Fig. 5C . Immunohistochemical staining for both HB-EGF and EGF receptor was more pronounced in left ventricular tissue of 9-week-old SHR than in similarly aged WKY Ž . Fig. 1 . A: double products sBP=HR in untreated SHR and WKY as a function of age. Open bar, WKY; hatched bar, SHR. ns6 in each group at each time point. ) P -0.01 vs. age-matched WKY. B: double products in 9-week-old SHR-treated with enalapril, atenolol, or both. Saline-treated SHR and WKY are shown for comparison. ns6 in each group. ) ) P -0.01 vs. saline-treated WKY. Ž . Fig. 4A ,B, and Fig. 5A ,B , whereas the negative controls Ž . normal rabbit and mouse serum did not react with any rat Ž . tissue sample Fig. 4D and Fig. 5D .
Morphologic and hemodynamic changes in treated SHR and WKY
Beginning at 4 weeks of age, SHR were treated for 5 weeks with enalapril, atenolol, or both. When compared with rats treated with vehicle alone, enalapril and enalapril q atenolol significantly reduced the systolic blood pres-Ž . sure P -0.01 vs. vehicle SHR , whereas atenolol was not Ž . effective Table 2 . In contrast, the heart rate was sup-Ž pressed by atenolol and enalaprilq atenolol P -0.01 vs.
. Ž . vehicle SHR , but not by enalapril alone Table 2 . While the body weight was similar in these groups of rats, enalaprilq atenolol decreased LVrBW more than either Ž . Ž . alone P -0.01 vs. vehicle SHR Table 2 . When we calculated double products in these treated rats, we observed that this parameter was moderately reduced by either enalapril or atenolol, but more markedly by their Ž 2 combination 9-week vehicle WKY, 474 " 24 = 10 ; 9-week vehicle SHR, 931 " 44 = 10 2 ; 9-week enalapril SHR, 627 " 37 = 10 2 ; 9-week atenolol SHR, 646 " 10 = 10 2 ; 2 . Ž 9-week enalaprilq atenolol SHR, 468 " 13 = 10
Fig. . 1B . In particular, treatment with both drugs was more effective in reducing the mechanical load and LVH than treatment with either drug alone.
Effects of drug treatment on expression of HB-EGF and EGF-receptor mRNA
The overexpression of HB-EGF mRNA, previously ob-Ž . served in 9-week-old SHR Fig. 2 , was suppressed slightly by treatment with either enalapril or atenolol, and moder-Ž . ately by both reagents together Fig. 6 . Although enalapril q atenolol reduced the expression of HB-EGF mRNA to Ž . 79% of that seen with vehicle-treated SHR P -0.05 , this Ž .Ž level was still twice that seen in WKY P -0.01 Fig. . 6A,B . We observed no significant change in the expression of EGF-receptor mRNA in rats treated with atenolol, Ž . enalapril, or both data not shown .
Discussion
Our finding, that the expression of HB-EGF mRNA and protein are enhanced in the left ventricle of SHR, suggests that this growth factor may play an important role during the early development of LVH and cardiac fibrosis in SHR.
Indeed, we showed that the overexpression of HB-EGF mRNA was transient, peaking at 9 weeks of age and then declining. This transient enhancement in the early stage of cardiac hypertrophy may indicate that HB-EGF is especially important for the initiation of the hypertrophic process, but less important for the maintenance of hypertrophy in SHR. Although it is still not fully understood what kind of factors promote cardiac hypertrophy in SHR, we speculate HB-EGF is a possible candidate for one of those factors.
The discrepancy between the transient enhancement of HB-EGF mRNA expression and the continual enhancement of EGF-receptor mRNA expression in SHR remains to be clarified. It has been reported that EGF itself reguw x lates the expression of EGF-receptor mRNA 26 , suggesting that the enhanced expression of HB-EGF mRNA in the early stages of LVH induces increased expression of EGF-receptor mRNA. Since the induction of proliferation by EGF has been found to be proportional to EGF-receptor w x density in SMC of SHR 15 , it raises the possibility that the expression of EGF-receptor in SHR is regulated by a genetic factor. Other members of the EGF subfamily, such as EGF, TGF-a, amphiregulin, and betacellulin, which also activate the EGF-receptor, may also play a role in the maintenance of LVH in SHR by continually stimulating the enhanced expression of the EGF-receptor.
It is also possible that the increased steady-state levels of HB-EGF and EGF-receptor mRNA that we observed in SHR were due to decreased degradation of these transcripts rather than increased synthesis. In primary cultures of rat neonatal and adult cardiac myocytes, however, increased levels of HB-EGF mRNA induced by the aadrenoreceptor agonist, phenylephrine, were shown to be caused by increased gene transcription, not by altered w x stability of this message 8 . In addition, our immunohistochemical experiments demonstrated that the increased levels of HB-EGF and EGF-receptor transcripts in SHR were mirrored by increased levels of their respective proteins. We believe that the enhanced expression of HB-EGF and its receptor mRNA leads to the increases in their protein level.
It is noteworthy that the peak of HB-EGF mRNA expression coincided with the peak of double products Ž . sBP = HR , a hemodynamic indicator of mechanical stress, in SHR. In addition, treatment of these rats with both atenolol and enalapril reduced double products more effectively than treatment with either alone, and only treatment with both drugs significantly reduced the expression of HB-EGF mRNA. These intriguing observations suggest that mechanical stress may be associated with the enhanced expression of HB-EGF mRNA. This is supported by our experiments in which SHR were treated with hydralazine. This agent reduced sBP as markedly as did enalapril, and affected HB-EGF mRNA expression to the same degree as either enalapril or atenolol. When administered together with atenolol, however, hydralazine significantly reduced the double products and suppressed the Ž . expression of HB-EGF mRNA data not shown .
Increased mechanical stress has been shown to stimulate protein synthesis and to induce the expression of several fetal and immediate early genes in isolated perw x fused hearts 27 as well as in isolated cardiomyocytes w x 28,29 . Opening of the stretch-activated cation channel is one proposed mechanism by which stress-protein synthesis w x is activated 30 . Interestingly, EGF has been reported to affect the cardiac contractile frequency that operates through the voltage-dependent calcium channels and the2q w x stimulation of Na rH and Na rCa exchange 31 . In addition, overexpression of HB-EGF mRNA has been found to be induced by chronotrophic stimuli activated by w x electric pacing in isolated cultured myocytes 8 , and by w x shear stress in human vascular endothelial cells 32 . These findings, along with the results reported here, suggest a possible link between increased myocardial stress and enhanced expression of HB-EGF mRNA, leading to a hypertrophic response in the myocardium, at least in the early phases of hypertension and cardiac hypertrophy in SHR.
Since both enalapril, an angiotensin-converting enzyme inhibitor, and atenolol, a b -adrenoreceptor antagonist, 1 Downloaded from https://academic.oup.com/cardiovascres/article-abstract/38/2/365/299544 by guest on 10 December 2018 ( )reduced LVrBW ratios, but neither drug alone significantly affected the expression of HB-EGF mRNA, it is unlikely that the enhanced expression of HB-EGF message observed in untreated SHR is the result of cardiac hypertrophy. Although we could not exclude the role of the renin-angiotensin system, which is modulated by enalapril, or the sympathetic signal transduction system, which is modulated by atenolol, in the enhancement of HB-EGF mRNA expression, we believe it more likely that HB-EGF expression is independent of these humoral or neural mechanisms, and is related more to mechanical stress.
Another possible role of HB-EGF in LVH of SHR may be to promote the proliferation of interstitial cells, especially the fibroblasts. An increased synthesis of collagen, as well as a subsequent increase in total collagen, have been observed at 4-8 weeks of age, and later at 24 weeks w x in SHR 33 . It has been suggested that the expression of collagen gene isoforms, as well as the expression of ANP and skeletal a-actin mRNA, are enhanced in 9-week-old w x SHR compared to WKY 34 , and that a direct interaction between HB-EGF and adhesion molecules may regulate w x cell proliferation in the cell-to-cell adhesion process 35 . We detected HB-EGF primarily in myocyte membranes, whereas EGF receptor was observed mainly in interstitial area, primarily in the fibroblasts. These results suggest that HB-EGF may regulate fibroblast proliferation in the hypertrophied hearts of SHR by a paracrine or juxtacrine mechanism.
In summary, the results of the present investigation demonstrate, for the first time, an enhanced expression of HB-EGF and its receptor, particularly during early development of LVH in SHR. The mechanism seems to be operated, at least in part, through the enhanced mechanical stress during this particular stage of SHR, and might, in turn, contribute to the remodeling of hypertensive hypertrophied heart. 
